Table 1.
The characteristics of all included studies.
| Author and reference | Year | Total sample | Control/treatment | Period of treatment (day) | Drug | Evaluation standard | |
|---|---|---|---|---|---|---|---|
| C | T | ||||||
| Li Jiayun [12] | 2019 | 108 | 54/54 | 60 | (1), (4), (6) | (11) | 1, 3, 9 |
| Lu Jiansheng [13] | 2018 | 64 | 32/32 | 60 | (1), (3), (6) | (11) | 1, 3, 7, 8, 11 |
| Jiao Lixing [14] | 2015 | 78 | 39/39 | 30 | (1), (10) | (11) | 1, 3, 8, 12 |
| Zhao Dongkai [15] | 2015 | 100 | 50/50 | 30 | (14) | (11) | 1, 2, 4 |
| Huang Wenhua [16] | 2018 | 71 | 35/36 | 30 | (1), (2) | (11) | 1, 4 |
| Li Tingai [17] | 2019 | 110 | 55/55 | 30 | (1), (2), (3)③ | (11) | 1, 5 |
| Fang Yuxiang [18] | 2009 | 117 | 57/60 | 28 | (1), (2)② | (11) | 1, 7, 8, 13 |
| Ying Ping [19] | 2018 | 100 | 50/50 | 60 | (1), (3), (4) | (11) | 1, 6, 7 |
| Wang Baoxin [20] | 2010 | 58 | 29/29 | 30 | (1), (8) | (11) | 1, 4 |
| Fang Jianjia [21] | 2008 | 60 | 30/30 | 28 | (2), (3) | (11) | 1, 2, 14 |
| Lin Zhijuan [22] | 2015 | 70 | 30/40 | 30 | (1), (2), (3), (9), (13) | (11) | 2, 6, 15 |
| Song Yuxin [23] | 2013 | 82 | 40/42 | 28 | (1), (6), (7), (9) | (11) | 1, 2, 5, 7 |
| Lv Xiqi [24] | 2019 | 100 | 50/50 | 60 | (1), (3), (5) | (11) | 1, 7 |
| Li Guangcheng [25] | 2009 | 80 | 40/40 | 30 | (1), (2) | (11) | 1, 2, 5 |
| Yang Suqing [26] | 2015 | 96 | 48/48 | 28 | (1), (2), (3) | (11) | 1, 3, 5 |
| Zhang Guangyu [27] | 2018 | 92 | 46/46 | 28 | (1), (3), (8) | (11) | 1, 3, 4 |
| Liang Lifeng [28] | 2015 | 100 | 50/50 | 28 | (6), (7), (9) | (11) | 1, 2, 7 |
| Cai Xiaoming [29] | 2017 | 96 | 48/48 | 28 | (6), (7), (9) | (11) | 1 |
| Zhou Fei [30] | 2019 | 80 | 40/40 | 28 | (6), (7) | (11) | 1, 2, 6 |
| Zhang Mingli [31] | 2010 | 80 | 40/40 | 28 | (2), (7), (9) | (11) | 1, 2, 7 |
| Cheng Lisheng [32] | 2015 | 92 | 46/46 | 28 | (3), (4), (10) | (11) | 1, 2, 4, 7 |
Abbreviations: (1) aspirin; (2) nitroglycerin; (3) isosorbide dinitrate/isosorbide mononitrate; (4) metoprolol; (5) nifedipine; (6) nitrates; (7) β-blocker; (8) Betocloc; (9) calcium antagonist; (10) captopril; (11) Xuefu Zhuyu Decoction based on the control group; (12) lipid-lowering agents and pain relief drugs; (13) clopidogrel and atorvastatin; (14) Compound Salvia Tablets. 1 Total therapeutic effect; 2 ECG; 3 adverse reaction; 4 angina pectoris attack frequency and duration; 5 the total effective of TCM syndromes; 6 serum lipid index; 7 blood stream change; 8 the effect of electroacupuncturing acupoint; 9 vessel endothelial function and factors of vessel endothelium; 10 LVEF and PAF; 11 average hospital stay; 12 disappeared time of angina; 13 effects of decreased dose; 14 symptom improvement; 15 the total angina pectoris efficacy.